Melphalan Hydrochloride API Market Size, Share, Growth, and Industry Analysis, By Type (Purity≥98%, Purity<98%), By Application (Injection, Others) and Regional Forecast to 2033

MELPHALAN HYDROCHLORIDE API MARKET REPORT OVERVIEW

The global Melphalan Hydrochloride API Market is poised for significant growth, starting at USD 0.3 billion in 2024, rising to USD 0.32 billion in 2025, and projected to reach USD 0.51 billion by 2033, with a CAGR of 6% from 2025 to 2033.

Melphalan hydrochloride is a drug that is used for the treatment of cancer of various types. It is an activating agent and attack on cells. Melphalan is used in treatment of multiple myeloma, polycythaemia vera, childhood neuroblastoma, and others. Some patients who cannot take this drug by mouth to treat multiple myeloma for palliative therapy use a mixture of one form of melphalan hydrochloride. API is a component that is used for drug activation.

With rising concern of increasing cancer globally and demand of effective treatment gives vast opportunities for the growth of this market. To develop various types of drugs for different levels of treatment and to provide in the inject form and others also enhance the growth of this market.

COVID-19 Impact: Market Growth Hampered by Pandemic due to Delay in Manufacturing

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic affected this market due to the trouble in the manufacturing process. The obstruction in the manufacturing by the companies affected the production of medicine at the proper time. This problem has affected the operation for many key players in the market. However, due to the pandemics there was a rise in the awareness of good health and due to fast rate of increase of the different types of cancer has also increased and has opened the opportunities for growth of the market.

LATEST TRENDS

Some of the latest trends in this market of API are such as the first trend is, for developing a gene therapy using zinc finger protein, Sangamo and Pfizer companies have collaborated for the treatment of mutation of gene that includes FTLD and ALS. Another trend is that in the U.S, a launch of new product Melphalan Hydrochloride for injection by the Dr. Reddy’s laboratory.

MELPHALAN HYDROCHLORIDE API MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Purity≥98%, Purity<98%

• Purity≥98%: In this market type, the API purity level will be greater than or equal to the 98 percent means that the API is highly concentrated and can deliver high results with minimum 98% guarantees.
• Purity<98%: In this market type, the API purity level will be lesser than the 98 percent means that the API is less highly concentrated and can deliver a lower result with maximum less than 98% guarantees.

By Application

Based on application the market can be categorized into Injection, Others

• Injection: In this application segment, the melphalan hydrochloride API comes in the form of injection that is used for the patients who cannot take the drug by mouth.
• Others: The other form of application of this API is in the form of tablets that are used for treatment of bone marrow, and others.

DRIVING FACTORS

"Increasing Cancer the Expand the Market Extremely"

It is one of the key driving factors for the Melphalan Hydrochloride API Market Growth due to the increase in the incidence of cancer at a high rate. The treatment of cancer will also increase as the rate of cancer expands. As a result, the market is expected to expand in the coming year.

"Technological Advancement Amplifies the Market Growth"

As the technologies are helping every sector to grow and produce developed and innovative products, the advanced technologies are helping this market and also the government investment in expanding the API market. The treatment of various types of cancer are being developed and with innovation by the top companies. These innovative treatments are amplifying the growth of the market.

RESTRAINING FACTOR

"Counterfeit Drugs Restrict the Market Growth"

The most important restricting factor for hindrance of the market growth is the availability of the substandard API. Due to this it becomes difficult to identify and cause serious problems. Also this medicine increases the risk of receiving other types of cancer.

MELPHALAN HYDROCHLORIDE API MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America Dominates the Market due to Increasing Incidence of Cancer"

The North America region is dominating the Melphalan Hydrochloride API Market Share due to the high increase in the number of cases of cancer in this region along with the increase in the expenditure for healthcare. The growth in the awareness of this active pharmaceutical ingredient has expanded the market share. On the other hand, the Asia Pacific region is also expecting to grow fast with an increase in the various types of cancer in this region.

KEY INDUSTRY PLAYERS

Many prominent industry players are operating in this market focused on providing high quality and affordable treatment for cancer. However, there are limited top companies but to expand in the market, companies used some techniques such as merger, acquisitions, partnership and using new advanced technologies for producing and developing new products for the treatment of the different types of cancer.

List of Market Players Profiled

• AUROBINDO PHARMA LTD (India)
• GRANULES INDIA LTD (India)
• NAVINTA LLC (U.S.)
• HETERO LABS LTD (India)
• SHILPA MEDICARE LTD (India)
• BIOPHORE INDIA PHARMACEUTICALS PVT LTD (India)
• NERPHARMA SRL (Italy)
• FARMABIOS SPA (Italy)
• EMCURE PHARMACEUTICALS LTD (India)
• OLON SPA (Italy)

INDUSTRIAL DEVELOPMENT

August 2023: A pharmaceutical corporation company, Apotex based in Canada has got permission of a new dosage form which has melphalan hydrochloride as an activating agent. The name of this drug is Melpahan Hydrochloridenda.

REPORT COVERAGE

This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global melphalan hydrochloride API market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.